IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 51-75 out of 1324.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

Public Release: 18-May-2015
Annals of Internal Medicine
ACP releases High Value Care screening advice for 5 common cancers
In a paper published in Annals of Internal Medicine, the American College of Physicians issued advice for screening average risk adults without symptoms for five common cancers: breast, colorectal, ovarian, prostate, and cervical. In a companion piece also published in Annals, ACP outlined a framework for thinking about the value of varying intensities of cancer screening.

Contact: Steve Majewski
SMajewski@mail.acponline.org
American College of Physicians

Public Release: 18-May-2015
Digestive Disease Week
Study finds non-invasive colon cancer screening may be promising for African-Americans
In a first-of-its-kind clinical trial, physician-scientists at University Hospitals Case Medical Center Seidman Cancer Center and Case Western Reserve University School of Medicine found that a new non-invasive technology for colon cancer screening is a promising alternative to colonoscopy for African-Americans. The study recruited patients to compare the effectiveness of stool DNA testing with colonoscopy for detecting large colon polyps.
NIH/National Cancer Institute

Contact: Alicia Reale
alicia.reale@uhhospitals.org
University Hospitals Case Medical Center

Public Release: 18-May-2015
Nature Methods
New device successfully captures metastasis-associated circulating tumor cell clusters
The latest version of a microfluidic device for capturing rare circulating tumor cells (CTCs) is the first designed specifically to capture clusters of two or more cells, rather than single cells. These CTC clusters appear gnificantly more likely to cause metastases than single circulating tumor cells.
National Institutes of Health, NIH/National Institute of Biomedical Imaging and Bioengineering, Stand Up to Cancer, Howard Hughes Medical Institute, Prostate Cancer Foundation, Charles Evans Foundation, Johnson and Johnson

Contact: Katie Marquedant
kmarquedant@partners.org
617-726-0337
Massachusetts General Hospital

Public Release: 18-May-2015
Annals of Internal Medicine
Not all women with dense breasts need more imaging; ACP advises 'smarter' cancer screening
Not all women with dense breasts are at high enough risk for breast cancer to justify additional imaging after a normal mammogram, according to a study published in Annals of Internal Medicine. Women with specific types of dense breasts who also have a high five-year cancer risk should discuss supplemental screening strategies with their doctors.

Contact: Angela Collom
acollom@acponline.org
215-351-2653
American College of Physicians

Public Release: 18-May-2015
Nature Methods
Microchip captures clusters of circulating tumor cells -- NIH study
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads. The work was funded by the National Institute of Biomedical Imaging and Bioengineering, part of the National Institutes of Health.
NIH/National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health

Contact: Margot Kern
nibibpress@mail.nih.gov
301-496-3500
NIH/National Institute of Biomedical Imaging & Bioengineering

Public Release: 18-May-2015
Nature Immunology
UCSF-led study explains how early childhood vaccination reduces leukemia risk
A team led by UCSF researchers has discovered how a commonly administered vaccine protects against acute lymphoblastic leukemia, the most common type of childhood cancer.
National Institutes of Health, NIH/National Cancer Institute, Leukemia and Lymphoma Society, William Lawrence and Blanche Hughes Foundation, California Institute for Regenerative Medicine, Wellcome Trust, Cancer Research UK

Contact: Juliana Bunim
juliana.bunim@ucsf.edu
415-502-6397
University of California - San Francisco

Public Release: 17-May-2015
American Thoracic Society
New England Journal of Medicine
Study validates effectiveness of genomic test for lung cancer detection
A new test co-developed by a Boston University School of Medicine researcher will allow patients suspected of having lung cancer to be subjected to fewer and less-invasive tests to determine if they have the disease.
Allegro Diagnostics Corp., National Institutes of Health, NIH/National Cancer Institute

Contact: Gina DiGravio
ginad@bu.edu
617-638-8480
Boston University Medical Center

Public Release: 15-May-2015
American Urological Association 2015 Annual Meeting
Fee-for-service health care may lead to higher risk for robotic prostate surgery patients
A 'perverse disincentive' for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led by Henry Ford Hospital researchers.

Contact: Tammy Battaglia
Tammy.Battaglia@hfhs.org
248-881-0809
Henry Ford Health System

Public Release: 15-May-2015
Cancer Epidemiology, Biomarkers & Prevention
Cancer survivors have evolving information needs
Judging by the nature and topics of their information seeking, cancer patients' information needs appear to differ depending on the type of cancer they have and where they are in their survivorship.
NIH/National Cancer Institute, NIH/Eunice Kennedy Shriver National Institutes of Child Health and Human Development, University of Minnesota Deborah E. Powell Center for Women's Health

Contact: Jacquie Posey
jposey@asc.upenn.edu
215-898-6460
University of Pennsylvania Annenberg School for Communication

Public Release: 15-May-2015
American Urological Association 2015 Annual Meeting
Myriad validates active surveillance threshold with Prolaris® for men with prostate cancer
Myriad presented clinical data for its Prolaris test at the 2015 American Urological Association Annual Meeting that showed the significant ability of the Prolaris test to help physicians improve care for men diagnosed with prostate cancer. New clinical validation data were presented that establish an active surveillance (AS) threshold for men with localized prostate cancer. The AS threshold is a composite of the Prolaris test score and clinicopathologic features.

Contact: Ron Rogers
rrogers@myriad.com
908-285-0248
Myriad Genetics, Inc.

Public Release: 15-May-2015
Scientific Reports
New screening method for prostate cancer recurrence
Researchers in the Quantitative Light Imaging Laboratory at the Beckman Institute for Advanced Science and Technology at the University of Illinois used spatial light interference microscopy in order to identify patients at higher risk for prostate cancer recurrence.
National Science Foundation, Agilent Laboratories

Contact: Maeve Reilly
mjreilly@illinois.edu
217-244-7316
Beckman Institute for Advanced Science and Technology

Public Release: 14-May-2015
2015 American Society of Clinical Oncology Annual Meeting
PharmaMar announces new advances in oncology at ASCO 2015 for compounds YONDELIS® and PM1183
PharmaMar announces new advances in oncology at ASCO 2015 for its compounds YONDELIS® and PM1183 highlighting data in small cell lung cancer, soft tissue sarcoma, and mesothelioma.

Contact: Carolina Pola
cpola@pharmamar.com
34-608-933-677
Pharmamar

Public Release: 14-May-2015
Frontiers in Neurology
Geneticists clock genetic differences between 'larks' and 'owls'
A new study from University of Leicester uncovers clues for 'morningness' and 'eveningness.'
Biotechnology and Biological Sciences Research Council

Contact: Dr Eran Tauber (PhD)
et22@le.ac.uk
44-011-625-23455
University of Leicester

Public Release: 14-May-2015
New release of Glioblastoma Atlas sheds light on deadly disease
Robust new data added to the Ivy Glioblastoma Atlas Project changes the scope and impact of this publicly available resource for researchers and clinicians searching for treatments for this most deadly and aggressive of brain cancers, glioblastoma multiforme.
Ben and Catherine Ivy Foundation

Contact: Rob Piercy
robp@alleninsitute.org
206-601-8441
Allen Institute

Public Release: 14-May-2015
Molecular Cell
Scientists discover how a promising anti-leukemia drug harms cancer cells
Due to overwhelming evidence of their effectiveness in mice, inhibitors of the leukemia protein BRD4, including the drug JQ1, moved into clinical trials starting in 2013. There are 12 trials targeting BRD4 in progress. Last year, clinical trial findings indicated that an oral inhibitor of BRD4 similar to JQ1 had led to complete remission in some patients. Now a team at CSHL has determined the pathway through which JQ1 acts.
National Institutes of Health, Alex's Lemonade Stand Foundation, V Foundation, Martin Sass Foundation, Lauri Strauss Leukemia Foundation, Burroughs Wellcome Fund, Japan Society for the Promotion of Science, Boehringer Ingelheim Fonds

Contact: Peter Tarr
tarr@cshl.edu
516-367-8455
Cold Spring Harbor Laboratory

Public Release: 14-May-2015
JAMA Otolaryngology - Head & Neck Surgery
Study examines treatment factors associated with oral cavity cancer survival
The surgical procedure known as neck dissection to remove lymph nodes and receiving treatment at academic or research institutions was associated with improved survival in patients with stages I and II oral cavity squamous cell cancer, according to a report published online by JAMA Otolaryngology-Head & Neck Surgery.

Contact: Ziba Kashef
ziba.kashef@yale.edu
203-436-9317
The JAMA Network Journals

Public Release: 14-May-2015
Cancer Research
Contraceptive and cholesterol-lowering drugs used to treat cancer
The combination of a cholesterol-lowering drug, Bezafibrate, and a contraceptive steroid, Medroxyprogesterone Acetate, could be an effective, non-toxic treatment for a range of cancers, researchers at the University of Birmingham have found.

Contact: Luke Harrison
l.harrison.1@bham.ac.uk
University of Birmingham

Public Release: 14-May-2015
Cancer Research
Revealing kidney cancer's secret
An international team of scientists, led by UC Davis nephrologist Robert Weiss, have used a sophisticated combination of proteomics and metabolomics to show how renal cell carcinoma reprograms its metabolism and evades the immune system.
National Institutes of Health, US Department of Veterans' Affairs, LLNL-UCDCC Fitzpatrick Award, Paula Moss Trust, J. Randall and Kathleen L. MacDonald Research Fund

Contact: Dorsey Griffith
dgriffith@ucdavis.edu
916-734-9118
University of California - Davis Health System

Public Release: 14-May-2015
American Journal of Public Health
Campaign increases mouth and throat cancer screenings among low-income rural Floridians
Raising awareness of the dangers of mouth and throat cancer increased the number of black men in some of Florida's poorest counties who sought screening for the first time, opening the door to improved survival rates through early detection and treatment, UF Health researchers report.

Contact: Elizabeth Hillaker-Downs
ehdowns@ufl.edu
352-265-7923
University of Florida

Public Release: 14-May-2015
American Society of Clinical Oncology (ASCO)
Experimental immunotherapy shows high response rate in advanced lung cancer
An early phase study testing an anti-PDL1 agent in combination with standard chemotherapy in the treatment of advanced non-small cell lung cancer has provided promising early results, prompting multiple phase III studies in lung cancer.
Genentech

Contact: Karen Teber
km463@georgetown.edu
Georgetown University Medical Center

Public Release: 14-May-2015
Proceedings of the National Academy of Sciences
Georgia State research paves way for early detection of liver cancer
Led by Georgia State University, researchers have developed the first robust and noninvasive detection of early stage liver cancer and liver metastases, in addition to other liver diseases, such as cirrhosis and liver fibrosis.
National Institutes of Health

Contact: Brian Mullen
bmullen@gsu.edu
404-413-5464
Georgia State University

Public Release: 14-May-2015
ecancermedicalscience
Unemployment linked to rise in prostate cancer deaths
The knock-on effects of the economic downturn have been explored in economy and psychology. Now researchers are examining the effects of unemployment on an even darker subject -- cancer mortality. One would think that dealing with unemployment was challenge enough. But according to the latest research published in ecancermedicalscience, rises in unemployment are associated with significant increases in prostate cancer mortality.

Contact: Audrey Nailor
audrey@ecancer.org
44-011-790-94742
ecancermedicalscience

Public Release: 14-May-2015
JAMA Oncology
Smoking induces early signs of cancer in cheek swabs
DNA damage caused by smoking can be detected in cheek swabs, finds research published today in JAMA Oncology. The study provides evidence that smoking induces a general cancer program that is also present in cancers which aren't usually associated with it -- including breast and gynecological cancers.
Eve Appeal

Contact: Wesley Hutchins
Wesley.Hutchins@eveappeal.org.uk
44-760-50108
University College London

Public Release: 13-May-2015
2015 American Society of Clinical Oncology Annual Meeting
Tumor sequencing study highlights benefits of profiling healthy tissue as well
As the practice of genetically profiling patient tumors for clinical treatment decision making becomes more commonplace, a recent study from The University of Texas MD Anderson Cancer Center suggests that profiling normal DNA also provides an important opportunity to identify inherited mutations that could be critical for patients and their families.

Contact: Clayton R. Boldt
crboldt@mdanderson.org
713-792-9518
University of Texas M. D. Anderson Cancer Center

Public Release: 13-May-2015
2015 ASCO Annual Meeting
New cancer treatment and prevention studies signal major advances for children and adults
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.

Contact: Alise Fisher
alise.fisher@asco.org
571-483-1354
American Society of Clinical Oncology

Showing releases 51-75 out of 1324.

<< < 1 | 2 | 3 | 4 | 5 | 6 | 7 > >>

  Search News Releases

     

 

EurekAlert!